107 related articles for article (PubMed ID: 36861801)
1. Can the New BA.2.75 Sub-variant Lead To One More COVID-19 Wave?
Ray SK; Mukherjee S
Infect Disord Drug Targets; 2023; 23(4):e020323214247. PubMed ID: 36861801
[TBL] [Abstract][Full Text] [Related]
2. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2.
Parums DV
Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166
[TBL] [Abstract][Full Text] [Related]
3. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.
Xia S; Wang L; Zhu Y; Lu L; Jiang S
Signal Transduct Target Ther; 2022 Jul; 7(1):241. PubMed ID: 35853878
[TBL] [Abstract][Full Text] [Related]
4. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
[TBL] [Abstract][Full Text] [Related]
5. Is Omicron the end of pandemic or start of a new innings?
Das S; Samanta S; Banerjee J; Pal A; Giri B; Kar SS; Dash SK
Travel Med Infect Dis; 2022; 48():102332. PubMed ID: 35472451
[TBL] [Abstract][Full Text] [Related]
6. The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends.
Farahat RA; Abdelaal A; Umar TP; El-Sakka AA; Benmelouka AY; Albakri K; Ali I; Al-Ahdal T; Abdelazeem B; Sah R; Rodriguez-Morales AJ
Infez Med; 2022; 30(4):480-494. PubMed ID: 36482957
[TBL] [Abstract][Full Text] [Related]
7. Genomic Diversity of SARS-CoV-2 Omicron Variant in South American Countries.
Luna N; Muñoz M; Ramírez AL; Patiño LH; Castañeda SA; Ballesteros N; Ramírez JD
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746705
[TBL] [Abstract][Full Text] [Related]
8. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms responsible for SARS-CoV-2 antibody waning and vaccine escape in Omicron sublineages BA.4 and BA.5.
Hewins B; Richardson C; Rubino S; Kelvin A; Toloue Ostadgavahi A; Kelvin DJ
J Infect Dev Ctries; 2022 Jul; 16(7):1122-1125. PubMed ID: 35905015
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
[TBL] [Abstract][Full Text] [Related]
11. Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study.
Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
Microbiol Spectr; 2022 Aug; 10(4):e0136722. PubMed ID: 35861527
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
[TBL] [Abstract][Full Text] [Related]
13. The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review.
Sarkar A; Omar S; Alshareef A; Fanous K; Sarker S; Alroobi H; Zamir F; Yousef M; Zakaria D
Hum Vaccin Immunother; 2023 Dec; 19(1):2212568. PubMed ID: 37254497
[TBL] [Abstract][Full Text] [Related]
14. The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages.
Xiang T; Wang J; Zheng X
Virol Sin; 2022 Dec; 37(6):786-795. PubMed ID: 36427646
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Omicron and its current known unknowns: A narrative review.
Le TTB; Vasanthakumaran T; Thi Hien HN; Hung IC; Luu MN; Khan ZA; An NT; Tran VP; Lee WJ; Abdul Aziz JM; Ali T; Dumre SP; Huy NT
Rev Med Virol; 2023 Jan; 33(1):e2398. PubMed ID: 36150052
[TBL] [Abstract][Full Text] [Related]
16. Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain).
Ciuffreda L; Lorenzo-Salazar JM; García-Martínez de Artola D; Gil-Campesino H; Alcoba-Florez J; Rodríguez-Pérez H; Íñigo-Campos A; Salas-Hernández J; Rodríguez-Nuñez J; Muñoz-Barrera A; Valenzuela-Fernández A; Díez-Gil O; González-Montelongo R; Flores C
Emerg Microbes Infect; 2023 Dec; 12(1):2202281. PubMed ID: 37039029
[No Abstract] [Full Text] [Related]
17. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.
Pather S; Madhi SA; Cowling BJ; Moss P; Kamil JP; Ciesek S; Muik A; Türeci Ö
Front Immunol; 2023; 14():1130539. PubMed ID: 37287979
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.
He X; Su J; Ma Y; Zhang W; Tang S
Front Immunol; 2022; 13():945930. PubMed ID: 36090988
[TBL] [Abstract][Full Text] [Related]
20. Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies.
Sah R; Rais MA; Mohanty A; Chopra H; Chandran D; Bin Emran T; Dhama K
Int J Surg Open; 2023 Jun; 55():100625. PubMed ID: 37255735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
